Related Experiment Video

Updated: Aug 21, 2026

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

Delayed thrombocytopenia following abciximab therapy

Edo Kaluski1, Marina Leitman, Inna Khiger

  • 1Assaf Harofeh Cardiology Institute and Coronary Care Unit, Zerifin, Israel.

International Journal of Cardiovascular Interventions
|May 31, 2002
PubMed

Insights

Delayed profound thrombocytopenia can occur five days after abciximab therapy, a glycoprotein (GP) IIb/IIIa inhibitor. These cases were self-limited and reversible without serious bleeding complications.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Glycoprotein (GP) IIb/IIIa inhibitors are crucial in treating acute coronary syndromes and percutaneous coronary interventions (PCIs).
  • Abciximab is an intravenous GP IIb/IIIa inhibitor used in approximately 35% of the >500,000 annual PCI patients in the USA.
  • Profound thrombocytopenia is a rare but serious side effect, typically occurring within 24 hours of abciximab administration.

Purpose of the Study:

  • To report three cases of delayed profound thrombocytopenia following abciximab therapy.
  • To discuss the pathophysiology, diagnosis, natural history, and management of this specific adverse event.

Main Methods:

  • Case series describing three patients who developed delayed profound thrombocytopenia.
  • Review of clinical data and outcomes related to abciximab administration.

Main Results:

  • Three patients experienced profound thrombocytopenia presenting five days after abciximab therapy.
  • All cases were self-limited and reversible.
  • No serious bleeding complications were observed in these patients.

Conclusions:

  • Delayed profound thrombocytopenia is a possible, albeit rare, complication of abciximab therapy.
  • Early recognition and monitoring are essential for managing abciximab-induced thrombocytopenia.
  • The self-limited nature of these cases suggests a favorable prognosis with appropriate management.

More Related Videos

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...